Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Celularity (CELU) Non-Current Debt (2024 - 2025)

Celularity (CELU) has disclosed Non-Current Debt for 2 consecutive years, with $36.5 million as the latest value for Q2 2025.

For Q2 2025, Non-Current Debt changed N/A year-over-year to $36.5 million; the TTM value through Jun 2025 reached $36.5 million, changed N/A, while the annual FY2024 figure was $35.9 million, N/A changed from the prior year.
Non-Current Debt hit $36.5 million in Q2 2025 for Celularity, roughly flat from $36.5 million in the prior quarter.
Across five years, Non-Current Debt topped out at $36.5 million in Q1 2025 and bottomed at $35.9 million in Q4 2024.